KEGG analysis revealed cross-targeting with Pathways in cancer, Pathways of neurodegeneration—multiple diseases, pathways of apoptosis, glioma, JAK–STAT signaling pathway, and cell cycle (Fig. 2E). This evidence concerns the gene SOAT1 and glioma.